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Abstract
Bacteria lose or gain genetic material and through selection, new variants become fixed in the population. Here we provide
the first, genome-wide example of a single bacterial strain’s evolution in different deliberately colonized patients and the
surprising insight that hosts appear to personalize their microflora. By first obtaining the complete genome sequence of the
prototype asymptomatic bacteriuria strain E. coli 83972 and then resequencing its descendants after therapeutic bladder
colonization of different patients, we identified 34 mutations, which affected metabolic and virulence-related genes. Further
transcriptome and proteome analysis proved that these genome changes altered bacterial gene expression resulting in
unique adaptation patterns in each patient. Our results provide evidence that, in addition to stochastic events, adaptive
bacterial evolution is driven by individual host environments. Ongoing loss of gene function supports the hypothesis that
evolution towards commensalism rather than virulence is favored during asymptomatic bladder colonization.
Citation: Zdziarski J, Brzuszkiewicz E, Wullt B, Liesegang H, Biran D, et al. (2010) Host Imprints on Bacterial Genomes—Rapid, Divergent Evolution in Individual
Patients. PLoS Pathog 6(8): e1001078. doi:10.1371/journal.ppat.1001078
Editor: David S. Guttman, University of Toronto, Canada
Received January 29, 2010; Accepted July 27, 2010; Published August 26, 2010
Copyright:  2010 Zdziarski et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Wu¨rzburg group was supported by the Deutsche Forschungsgemeinschaft (SFB479, TP A1; http://www.dfg.de). The Lund group was supported by
the Swedish Medical Research Council (http://www.vr.se/), the Royal Physiographic Society (http://www.fysiografen.se/), the Medical Faculty, Lund University, the
So¨derberg, O¨sterlund, Lundberg, Maggie Stephens, Persson and Wallenberg Foundations. The Go¨ttingen group was supported by a grant of the
Niedersa¨chsisches Ministerium fu¨r Wissenschaft und Kultur (http://www.mwk.niedersachsen.de/). These studies were carried out within the European Virtual
Institute for Functional Genomics of Bacterial Pathogens (CEE LSHB-CT-2005-512061; http://www.noe-epg.uni-wuerzburg.de/) and the ERA-NET PathoGenoMics
(Grant no. 0313937A and 0315436A; http://www.pathogenomics-era.net/index.php). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ulrich.dobrindt@ukmuenster.de (UD); Catharina.Svanborg@med.lu.se (CS)
. These authors contributed equally to this work.
¤ Current address: Institute for Hygiene, University of Mu¨nster, Mu¨nster, Germany
Introduction
Microbes have adapted many fascinating strategies to co-evolve
with their hosts. The specific immune response to surface antigens
drives the structural changes in influenza virus hemagglutinin and
serotype [1], the antigenic drift in trypanosomes [2] and the
immune evasion mechanisms in malaria [3]. Similar mechanisms
operate in bacteria, forcing them to vary their surface antigens and
to maintain critical functions encoded by those genes, even in the
presence of a fully functional immune response [4]. While such host-
modulated microbial elements have been extensively studied, less is
known about microbial adaptation to environmental signals inside
individual patients. Most importantly, a host-specific approach to
the analysis of genome-wide alterations has not been taken.
Urinary tract infections (UTIs) present an interesting and highly
relevant model for studying microbial adaptation. After establish-
ing significant numbers, the bacteria either cause severe and
potentially life threatening disease, or an asymptomatic carrier
state resembling the normal flora at other mucosal sites. Patients
with asymptomatic bacteriuria (ABU) may carry the same strain
for months or years and this outcome is advantageous for the
microbe as it can persist in a favored niche with little microbial
competition. ABU is also favorable for the host who may be
protected from re-infection if the carrier strain outcompetes new
invaders [5,6]. In our previous work, we reported that at least 50%
of ABU strains have evolved from virulent uropathogenic E. coli
(UPEC) strains by genome reduction, i.e. inactivation of genes
encoding virulence-associated factors, either by the accumulation
of point mutations or by deletions [7,8]. These observations
suggest that bacteria adapt to the urinary tract environment and
that this human host niche is suitable for understanding the
mechanisms involved. The determinants of long-term bacterial
persistence and adaptation to the host environment are, however,
still poorly understood. For these reasons, we looked at real-time
evolution by sequencing the progenitor strain E. coli 83972 and
then analyzing its re-isolates from several patients.
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The prototypic ABU E. coli strain 83972 has been extensively
used for therapeutic urinary bladder colonization in patients with
chronic UTI. After intravesical inoculation, the strain establishes
ABU and this approach has proven to be safe and to protect the
patient from super-infection with more virulent strains [6,9]. Here,
we compare the genomes, transcriptomes and proteomes of E. coli
83972 to re-isolates from patients deliberately colonized with this
strain. We provide evidence that the pattern of genetic and
phenotypic changes was distinct for each host and that it involves a
limited number of genes, including regulators, metabolic genes
and virulence factors.
Results
Complete genome sequence of the protype ABU E. coli
83972
To characterize the prototype ABU E. coli 83972, we solved the
chromosomal DNA sequence and compared it to genomes from
other UPEC strains (CFT073, UTI89, 536), enterohemorrhagic E.
coli (EHEC) strain O157:H7 Sakai and E. coli K-12 strain
MG1655. The E. coli 83972 genome, which was originally isolated
from the urinary tract of a schoolgirl [5], comprises a 5,131,397-bp
chromosome and a small 1,565-bp cryptic plasmid (Figure 1).
According to the genome sequence, E. coli 83972 was most closely
related to the UPEC strains in particular to CFT073, sharing four
chromosomal regions with only this strain (Figure 1, Table 1).
Notably, large parts of region 2 and 4 are identical to genomic
islands I and II of non-pathogenic E. coli strain Nissle 1917, a close
relative of UPEC strain CFT073 that evolved by reductive
evolution [10]. Six other islands were also shared with other
UPEC, but not with EHEC or E. coli K-12 (Figure 1, Table 1).
These genomic regions encode virulence and fitness-associated
factors, including iron-uptake systems, adhesins, toxins, the K5
capsule, different secretion systems, as well as metabolic traits and
transporters (Table 1). Other island-encoded traits shared with
UPEC and EHEC included type 1 fimbriae, mannonate hydrolase
(required for hexuronate degradation) and a C4-dicarboxylate
transporter.
Six prophages were identified which were unique in type or
chromosomal localization for E. coli 83972. Two of these are of
particular interest. We found that prophage 4 was similar to
prophages so far only described in the genomes of UPEC strain
IAI39 (accession no. CU928164) or Salmonella enterica serovar
Typhi (accession no. AE014613 or AL627270). In strain 83972, it
was inserted into the rstB gene which encodes for the sensor
histidine kinase RstB of the RstAB two-component system. The
RstAB system controls the expression of genes involved in diverse
processes relevant for bladder colonization, such as acid tolerance,
curli formation and anaerobic respiration [11,12]. Prophage 2 was
similar to EHEC prophages, disrupting focD and thus the F1C
fimbrial determinant in E. coli 83972.
Human colonization and the in vitro continuous culture
Here, we have established asymptomatic carriage of a single
bacterial strain in different human hosts and then, using re-isolates
obtained from these individuals, studied the host-specific genome-
wide changes. Therapeutic bacteriuria was established in six
patients by intravesical inoculation of E. coli 83972 (Figure 2A).
Afterwards, re-isolates obtained from each host at different times
(in vivo re-isolates) were subjected to genetic and phenotypic
analyses (Figure 2B). This was possible as E. coli 83972 establishes a
monoculture in the human urinary tract and because bacteriuria
often lasts for months or years. To distinguish genetic changes
driven by the host environment from random events, we cultured
E. coli 83972 in vitro in pooled human urine for more than 2000
generations and included corresponding isolates in the analysis.
Genome structure of re-isolates
By pulsed-field gel electrophoresis (PFGE), we observed
alterations in overall genome structure in 31% (5/16) of individual
in vivo re-isolates. The exhibited restriction pattern alterations
differed in comparison to the progenitor strain and also among
themselves (Figure S1A). In contrast, 17 independent isolates from
long-term in vitro cultivation showed no change in genome
structure, indicating that genomic alterations depended on
individual hosts rather than on preexisting hot spots of genomic
variability (Figure S1B). Larger changes in the genome size of in
vivo re-isolates were not observed, as analyzed by PFGE following
I-CeuI digestion, with the exception of strain PII-4 displaying a
reduction in genome size (Figure S2A). Analysis of multiple
colonies from the corresponding urine samples confirmed that the
genome variations were representative for each host and time of
sampling (Figure S2B).
Sequencing of re-isolates from inoculated patients and
in vitro control cultures
From the above candidates, we chose for genome sequencing
three re-isolates with altered PFGE pattern from three patients
and one randomly chosen in vitro propagated 83972 variant (E. coli
83972-4.9). Complete genome coverage was obtained and raw
sequences were mapped on the chromosome of the progenitor
strain E. coli 83972. After verification by single locus Sanger
sequencing, 37 loci in the four sequenced re-isolates were
confirmed to be polymorphic as compared to the parent strain.
We found that genomic alterations occurred within conserved and
flexible parts of the bacterial chromosome (Figure 3), and with
only three exceptions, these affected coding regions. The majority
of the alterations were single nucleotide polymorphisms (SNPs)
(2 synonymous vs. 27 non-synonymous substitutions), but one
Author Summary
Bacterial virulence results from the interaction between
bacteria and their hosts. This interaction provides selection
pressure for bacterial adaptation towards increased fitness
or virulence. Basic mechanisms involved in bacterial
adaptation at the genetic level are point mutations and
recombination. As bacterial genome plasticity is higher in
vivo than in vitro, host-pathogen interaction may facilitate
bacterial adaptation. Comparative genomics has so far
been almost entirely focused on genomic changes upon
prolonged bacterial growth in vitro. To achieve a better
comprehension of bacterial genome plasticity and the
capacity to adapt in response to their host, we studied
bacterial genome evolution in vivo. We analyzed the
impact of individual hosts on genome-wide bacterial
adaptation under controlled conditions, by administration
of asymptomatic bacteriuria E. coli isolate 83972 to several
hosts. Interestingly, the different hosts appeared to
personalize their microflora. Adaptation at the genomic
level included point mutations in several metabolic and
virulence-related genes, often affecting pleiotropic regu-
lators, but re-isolates from each patient showed a distinct
pattern of genetic alterations in addition to random
changes. Our results provide new insights into bacterial
traits under selection during E. coli in vivo growth, further
explaining the mechanisms of bacterial adaptation to
specific host environments.
In Vivo Adaptation of Uropathogenic E. coli
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inversion of 1,731-bp, one large 27-kb deletion and four small
deletions of 1, 5, 12 or 165 bp were also detected. Many altered
genes encoding proteins with regulatory functions (Figure 3, Table
S1) were independently acquired in multiple individual re-isolates
but not after in vitro culture and thus seemed to represent
adaptational hotspots in vivo. They included the BarA/UvrY two-
component system that controls a global regulatory network
affecting a multitude of cellular functions and that has been
proposed as a virulence trait in UTI [13], and mdoH encoding a
glycosyl transferase involved in osmoregulated periplasmic glucan
synthesis [14] as well as genes involved in oxidative stress responses
(frmR) [15].
In re-isolate PI-2, we found that nineteen different genomic
loci were mutated relative to the progenitor strain, and 89% of
these resulted in an altered amino acid sequence of the encoded
proteins. Interestingly, 35% of the above mutations were stop
codons and frame shifts. Furthermore, many of the mutations
impacted pleiotropic regulatory genes involved in adaptation to
different stress conditions including oxidative stress and/or
resistance to antibiotics (frmR, marR, oxyR) [16]. Osmolarity, and
virulence- or fitness-associated traits were also affected (barA,
ompR, ompC, mdoH). The genes barA and ompR are part of the two-
component systems OmpR/EnvZ and BarA/UvrY which
regulate flagella and adhesin expression, biofilm formation, and
glycolytic or gluconeogenic utilization of different carbon sources
[17,18].
In re-isolate PII-4, we found nine genomic alterations including
five non-synonymous SNPs, a frame shift in the gene encoding for
cellulose synthase bcsA, as well as huge deletion and one mutation
in a non-coding region. Most intriguingly, the last two mutations
affected iron uptake systems: aerobactin (iuc) and the ferric citrate
uptake system (fec). The aerobactin gene cluster was lost due to a
27-kb partial deletion of a pathogenicity island (Figure S2C) and
the fecI upstream region required for ferric citrate uptake was
polymorphic (T to C substitution). In addition, we detected
sequence alterations in genes encoding the transcriptional
repressor of ribonucleoside metabolism (cytR) and the transcrip-
tional repressor of ribose catabolism (rpiR).
Figure 1. Genetic map of the E. coli 83972 chromosome and the small plasmid pABU. Nucleotide sequence analysis of the E. coli 83972
chromosome a): The two most outer circles represent all putative open reading frames (ORFs), depending on ORF orientation. The following five
circles report the results of a two-way genome comparison between E. coli 83972 and one of the following E. coli strains: CFT073 (UPEC), 536 (UPEC),
UTI89 (UPEC), MG1655 (K-12) and Sakai (EHEC O157:H7). Genes shared between the strain pair compared are indicated in grey and variable genome
regions are indicated in red. The innermost circle represents the G+C distribution. Genomic regions only present in strains ABU83972 and CFT073 are
framed in red. Chromosomal segments framed in green or blue are only present in the ABU isolate and pathogenic E. coli or represent bacteriophage-
related DNA, respectively. Details on the gene content of these regions are compiled in Table 1. UPEC, uropathogenic E. coli; EHEC,
enterohemorrhagic E. coli. Nucleotide sequence analysis of plasmid pABU b): putative predicted ORFs have been indicated.
doi:10.1371/journal.ppat.1001078.g001
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In re-isolate PIII-4, we also observed mutations in barA and frmR.
In this strain, all six mutations affected coding sequences of
housekeeping genes, four of which were non-synonymous, one
nonsense mutation, and one was an internal deletion. Surprisingly,
we found SNPs in rpoC and gyrA, which was consistent with previous
studies of long-term in vitro experimental evolution [19,20].
In contrast to the in vivo re-isolates, the in vitro-propagated strain 4.9
showed only three genomic alterations: one predicted diguanylate
cyclase (yfiN) and in two phage-related genes (Figure 3; Table S1).
Genomic alterations in re-isolates obtained after a
second inoculation of each patient
To address the hypothesis that the host selects specific mutants or
‘imprints’ the pathogen during bladder colonization, we sequenced
selected genomic regions of the E. coli 83972 genome in re-isolates
from a second, independent inoculation of each patient. Thera-
peutic inoculations were repeated for medical reasons, urine
cultures were obtained at monthly intervals and five independent
bacterial colonies from the last sampling time point were subjected
to Sanger sequencing. Specifically, we examined chromosomal loci,
which were altered in E. coli 83972 re-isolates from the first
inoculation event in PI-2, PII-4 and PIII-4.
Several loci were repeatedly altered in re-isolates of strain 83972
from the same host (Table S2). This included the fecIR promoter
region where the re-isolate of the second bladder colonization of
patient PII carried a point mutation 23 nucleotides upstream of
the SNP previously detected in strain PII-4. Re-isolates from the
first and second inoculation in patients PI and PIII had different
point mutations in the frmR gene. The mdoH gene was mutated in
isolates PI-2 and PII-4 from the first inoculation and mutations
were detected in re-isolates from the second inoculation in all three
patients. In contrast, these genomic alterations did not occur in
five isolates from two independent in vitro urine cultures of E. coli
83972, further suggesting that the host environment may drive
seletion of these genomic changes.
Table 1. Genomic islands and prophages in the E. coli 83972 genome.
Genomic
region
Position in
the genome Encoded traits
Region 1a ECABU_c02290-
ECABU_c03230
Hemolysin expression modulating protein, put. iron transporter (absent in CFT073), put. PTS system, IgA-specific serine
endopeptidase, HlyD family secretion protein, put. oligogalacturonide transporter
Region 2a ECABU_c10540-
ECABU_c12460
Tagatose utilization, hemagglutinin-related protein (frame shift), microcin V, F1C fimbriae (inactivated due to prophage
2 insertion), salmochelin, antigen 43
Region 3a ECABU_c16830-
ECABU_c16980
Vgr-like proteins and hypothetical proteins (type VI secretion system)
Region 4a ECABU_c32560-
ECABU_c33710
ShiA-like protein, aerobactin, Sat autotransporter protease, antigen 43, K5 capsule, general secretion pathway,
glycolate utilization (glc operon)
Region Ib ECABU_c22350-
ECABU_c23330
Yersiniabactin biosynthesis (high pathogenicity island, HPI), colibactin polyketide biosynthesis
Region IIb ECABU_c30880-
ECABU_c31120
Vgr-related protein and hypothetical proteins (type VI secretion system)
Region IIIb ECABU_c36660-
ECABU_c36730
Ribose ABC transporter
Region IVb ECABU_c43120-
ECABU_c43350
PTS system, glucose-specific IIBC component, transketolase, transcriptional regulator, permease, glutamyl-tRNA(Gln)
amidotransferase subunit A, isochorismatase family protein, dienelactone hydrolase family protein, uridine
phosphorylase, 2-dehydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-oxoglutarate aldolase, 2-dehydro-3-
deoxygalactonokinase
Region Vb ECABU_c45860-
ECABU_c45960
Alanine racemase, aromatic amino acid aminotransferase, 2-oxoglutarate DH, C4-dicarboxylate transport transcriptional
regulatory protein
Region VIb ECABU_c48360-
ECABU_c49500
P fimbriae, F17-like fimbriae, cytotoxic necrotizing factor 1, a-haemolysin (internal stop codon), Fec siderophore system
Region VIIb ECABU_c49540-
ECABU_c49920
Type 1 fimbriae (fim) determinant (truncated), mannonate hydrolase (uxuABR), type I restriction-modification system,
C4-dicarboxylate transporter, Na+/H+ antiporter (island also present in EHEC Sakai strain)
Prophage 1c ECABU_c03450-
ECABU_c03720
E. coli 83972-specific prophage with IgA-specific serine endopeptidase determinant
Prophage 2c ECABU_c11290-
ECABU_c11990
Inserted into the focD gene
Prophage 3c ECABU_c13520-
ECABU_c14200
Iron/manganese transport system (Sit)
Prophage 4c ECABU_c18060-
ECABU_c18600
Inserted into the sensor histidine protein kinase gene rstB; similar to bacteriophage of UPEC isolate IAI39 or Salmonella
enterica sv. Typhi
Prophage 5c ECABU_c40840-
ECABU_c41030
E. coli 83972-specific prophage
Prophage 6c ECABU_c41260-
ECABU_c41440
E. coli 83972-specific prophage
aRegion present only in ABU83972 and CFT073, indicated by red in Fig. 1.
bRegion present only in ABU83972 and pathogenic E. coli (UPEC and EHEC), indicated by green in Fig. 1.
cProphages of ABU83972, indicated by blue in Fig. 1.
doi:10.1371/journal.ppat.1001078.t001
In Vivo Adaptation of Uropathogenic E. coli
PLoS Pathogens | www.plospathogens.org 4 August 2010 | Volume 6 | Issue 8 | e1001078
Stability of genomic alterations, examined in repeat
re-isolates
To examine if the genetic alterations might represent adaptive
changes that are cyclic in nature and that, in different patients, the
re-isolates were picked at different cycles, we obtained E. coli
83972 re-isolates at a time point distant from that of PI-2 and PII-
4 and subjected them to single locus Sanger sequencing. Most of
the SNPs (17/19), in isolate PI-2 were still present in its
progeny after an additional 126 days of bladder colonization. In
descendants of PII-4, 4 out of 9 genomic changes (mdoH, rpiR, fecI,
yejM) remained after an additional 125 days propagation time.
Interestingly, all detected alterations in the later re-isolates were
identical to those found in re-isolates PI-2 or PII-4. Isolate PIII-4
was the last sequential isolate derived from the inoculation of
patient PIII and comparisons could not be performed.
Characterization of individual bacterial adaptation by
transcriptome and proteome analysis of E. coli 83972
re-isolates
By comparing the three individual in vivo re-isolates and the in
vitro-propagated variant 4.9 to the progenitor E. coli 83872, we
observed differences in the respective phenotypes. Although
Figure 2. Therapeutic urinary tract inoculation with E. coli 83972. (A) Colonization scheme. Six patients received E. coli 83972 on three
consecutive days and bacteriuria was established. Re-isolates from urine were obtained at different time points after inoculation. (B) Schematic
representation of the sampling during human colonization. Arrows illustrate the time of colonization. Re-isolates obtained from different inoculations
of the same patient are represented on opposite sides of an arrow.
doi:10.1371/journal.ppat.1001078.g002
Figure 3. Localization of genomic alterations within the re-isolates’ genomes relative to parent E. coli 83972 as revealed by whole
genome sequencing. The nature of mutation is indicated by color: red- non-synonymous, grey- synonymous, black- intergenic, blue- deletion,
green- inversion.
doi:10.1371/journal.ppat.1001078.g003
In Vivo Adaptation of Uropathogenic E. coli
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growth characteristics in pooled human urine did not reveal major
variations between re-isolates (Figure S3A), these strains differed in
both motility and biofilm formation. The re-isolate PIII-4 was
more motile than the parent strain (Figure S3B). Regarding
biofilm formation, PI-2 formed significantly less biofilm than the
parent strain while PII-4 showed significantly more (Figure S3C).
To further determine whether stable genomic changes of
sequenced re-isolates (see previous section) affected the gene and
protein expression level, we subjected them to transcriptome and
outer membrane proteome (OMP) analysis. For this reason, prior
to either RNA or protein isolation bacteria were grown in vitro in
pooled human urine. Overall, the number of de-regulated genes,
as implicated by the transcriptome, was higher in the patient re-
isolates than in the in vitro-propagated variant 4.9 (Table 2). In
each strain, we identified distinct gene expression patterns
matching the proteome and genome data (Figure 4).
Studying re-isolate PIII-4, we found that its metabolism, motility
and stress responses were affected when compared to the
Table 2. Summary of global genomic alterations upon prolonged in vivo or in vitro growth of E. coli 83972.
Characteristics PI-2 PII-4 PIII-4 4.9
Source in vivo in vivo in vivo in vitro
Propagation time [days] 214 155 54 68
Normalized time factor 3.1 2.3 0.8 1
No. of de-regulated genes 87 85 271 13
No. of genomic changes 19 9 6 3
Individual number of mutations (per normalized
propagation time)
6.1 3.9 7.5 3
Up-regulated outer membrane proteins - Tsx, FecA, IroN, FepA IutA, FliC N/A
Down-regulated outer membrane proteins - Iha, IutA Imp, YeaT, IroN, FhuAE, FepA N/A
N/A, not analyzed.
doi:10.1371/journal.ppat.1001078.t002
Figure 4. Host-specific changes in gene expression patterns of E. coli 83972 revealed by transcriptome analysis. Hierarchical clustering
of de-regulated genes in in vivo re-isolates PI-2, PII-4 and PIII-4 and in vitro grown strain 4.9 relative to parent E. coli 83972 upon in vitro growth in
pooled human urine. Each horizontal line represents one gene; expression is given relative to the intensity bar (log 2-fold, mean values of . three
experiments). Unaffected genes are shown in black (p-value .0.09).
doi:10.1371/journal.ppat.1001078.g004
In Vivo Adaptation of Uropathogenic E. coli
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progenitor strain 83972. As already indicated by phenotypic tests,
this isolate showed increased motility. Indeed, flagellum and
chemotaxis determinants made up 32 of the upregulated genes
(Figure 4). OMP analysis further corroborated these results and
FliC was the most upregulated protein on the bacterial surface
(Figure 4). Against the background of generally impaired virulence
gene expression in E. coli 83972 and its re-isolates, this is the first
observation that expression of an immunogenic and functional
virulence factor, i.e. flagella, is increased in E. coli 83972 upon
prolonged in vivo growth. With regard to metabolic adaptations, we
detected 68 upregulated genes involved in diverse processes,
suggesting nutrition adaptation, e.g. sugar and sugar acid uptake
fuelling glycolysis (galacturonate, glucuronate, sialic acid, arabi-
nose and mannose), (see Figure S5A). Upregulated D-serine
uptake and its deamination pathway in PIII-4, together with
reduced glutamine uptake and degradation (downregulated glnALG
and glnHPQ operons, see Figure S5B), mirror adaptation to urine
as it is a nitrogen and D-serine-rich environment [21,22].
Utilization of the RNA degradation product pseudouridine, a
nucleoside present in human urine [23], was also upregulated in
strain PIII-4 as indicated by increased yeiC and yeiN gene
expression. In addition to multiple metabolic alterations, we
observed that genes frmAB were up-regulated when compared to
the progenitor strain. Accordingly, genome analysis of this re-
isolate demonstrated a corresponding point mutation in the frmR
gene.
In the second re-isolate (PI-2), we found that the majority of the
deregulated genes were also connected to growth and stress
responses (Figure 4). Growth-related genes required for peptide/
amino acid transport and utilization (degP, metNIQ, pepD, oppD, and
artJ), that have been reported to be essential for bacterial
multiplication in urine [24], were upregulated. As in the previous
re-isolate (PIII-4), the genes frmAB, which were proposed to
provide protection against oxidative or nitrosative stress [15], were
upregulated. In addition, marAB expression was upregulated,
corresponding to the genome sequence in which both marR and
marA displayed point mutations (Table S1). This is important
because the MarAB proteins are known to respond to oxidative/
nitrosative stress as well as to antimicrobial peptides [25]. We also
found that the expression of ribonucleotide-diphosphate reductase
required for DNA synthesis, replication and repair was increased.
It should be noted that expression of the ribonucleotide-
diphosphate reductase 2-encoding genes nrdHIEF, which are
increased by oxidative stress, is indirectly regulated by OxyR,
and that oxyR was mutated in re-isolate PI-2 (Table S1).
In isolate PII-4 we mainly identified alterations in central
intermediary metabolism and iron uptake, in contrast to the
possible stress adaptations in previous re-isolates. Upregulation of
the tsx, cdd, udp and deoABCD genes in re-isolate PII-4 (Figure 4, S7
and S8) indicated that ribo- and deoxyribonucleoside utilization
was enhanced. Resulting ribose-5-phosphate or deoxyribose-5-
phosphate could be channeled into the non-oxidative branch of
the pentose phosphate or the TCA cycle, respectively. Derepres-
sion of this catabolic pathway was probably due to a SNP in cytR
coding for a transcriptional repressor of the above-mentioned
determinants (Table S1). It may be hypothesized that such
adaptations could improve bacterial fitness as substantial amounts
of nucleic acids are accessible in urine due to bacterial
disintegration, exfoliation and lysis of bladder epithelial cells
[26]. We also found that iron homeostasis was affected. Expression
of ferric aerobactin receptor IutA was drastically reduced in re-
isolate PII-4 (Figure 4) what could be explained by the loss of the
aerobactin determinant through a 27-kb genomic deletion (Figure
S2C). As IutA is highly immunogenic [27], this deletion may
provide an adaptive advantage given the asymptomatic lifestyle of
E. coli 83972. Moreover, transcriptome analysis indicated that fec
transcript levels were significantly increased in this strain (Figure 4).
This was further corroborated by OMP analysis showing that
ferric dicitrate transporter FecA expression was upregulated
relative to the parent strain (Figure S7). Comparing genomes of
the 83972 progenitor and its descendant PII-4, we found a SNP in
the putative binding site of the ferric uptake regulator (Fur)
upstream of the fecIR regulatory genes (Table S1, Figure 3).
Reporter gene assays with the wild type or the PII-4 fecIR
upstream region that was fused with the promoterless luciferase
gene cluster uncovered 8-fold increase of the re-isolate promoter
activity (Figure 5A, S9). This result suggested differences in the
binding efficiency of the Fur protein to the polymorphic fecIR
promoter site of E. coli PII-4. To assess the molecular mechanisms
underlying increased fec expression on the DNA/protein binding
level, electrophoretic mobility shift assays (EMSA) were per-
formed. We found that this point mutation decreases binding
efficiency of Fur dimers to the altered Fur box on one DNA
strand. Consequently, in the re-isolate PII-4 strong Fur tetramer-
mediated repression of fecIR transcription was weakened resulting
in upregulation of the ferric dicitrate uptake (Figure 5B and C).
Interestingly, in the second inoculation re-isolate PII-B, we found
another SNP again present within the Fur binding site (Figure 5D).
Relationship between duration of colonization and
genomic alterations
The genomic analysis of re-isolates from the different time
points of patient colonization indicated a positive correlation
between the number of genetic changes and the colonization time.
However, if one normalizes the propagation time of the in vivo re-
isolates PI-2, PII-4 and PIII-4 to that of in vitro isolate 4.9, the
propagation time of the in vivo re-isolates exceeds that of E. coli 4.9
by factor 3.1, 2.3 and 0.8, respectively. By dividing the number of
genetic changes by the normalized propagation time of the isolate,
we were able to assess the individual extent of genomic alterations
upon in vivo and in vitro growth in urine (Table 2). Our data
indicate that the number of mutations was markedly higher in re-
isolates PI-2 and PIII-4 (2- and 2.5-fold, respectively) which,
according to their gene expression profiles, were subjected to
increased oxidative stress during bladder colonization (Figure 4).
In contrast, the mutation rate of E. coli PII-4, which did not show
adaptation to oxidative stress, was comparable to that of the in vitro
isolate 4.9.
Bacterial adaptation and innate host response
To examine if the host immune status might influence bacterial
adaptation, the innate immune response to inoculation was
quantified on a monthly basis with regard to Interleukin 6 (IL-6)
and Interleukin 8 (IL-8) concentrations and neutrophil infiltration.
In addition, urine samples were subjected to extended cytokine/
chemokine profiling (Figure 6).
Several interesting differences in the innate immune response
profile were observed between the patients. PI, with the highest
number of genomic alterations showed the highest IL-8 response
over time and the strongest neutrophil recruitment (Figure 6A and
B). In PIII neutrophil (p,0.0001) and IL-8 (p,0.008) responses
were not detected, but this patient showed the highest IL-6
response and had very high concentrations of IL-1RA in urine,
compared to PI and PII (p,0.005, Figure 6B and C). Some of the
host response differences were reproduced during the second
inoculation (Figure 6A). The results suggest that the patients
activate different aspects of the innate immune response to
infection.
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Discussion
Single bacterial surface antigens or virulence factor profiles are
known to vary under host immune pressure. For example, E. coli
isolates from recurrent bacteremia or chronic UTI often lose the
expression of long chain LPS, capsules or flagella [28,29] and
enterohemorrhagic E. coli may lose major virulence determinants
in the course of infection [30]. Data on genome-wide changes and
adaptation during long-term growth of E. coli in vitro has only
started to accumulate recently [31]. However, genomic alterations
involved in bacterial adaptation to individual human host
environments have largely not been studied. In this context, only
a few studies focused on analyses of sequential isolates obtained
from hosts persistently infected with Pseudomonas aeruginosa or
Helicobacter pylori [32,33]. They reported a loss of virulence due to
successive alterations in genome content and gene expression, but
the extent to which different human hosts modify single bacterial
genomes has not been investigated.
In our study, we have examined to which extent host imprinting
guides the evolution of adaptive genomic modifications during
asymptomatic bacterial carriage by comparing whole genomes,
transcriptomes and proteomes of the prototype ABU strain E. coli
83972 before therapeutic inoculation and after re-isolation from
several human hosts. The urinary tract inoculation protocol is a safe
and efficient way to prevent symptomatic infections in certain patient
groups [9] and allowed us to administer the same bacterial strain to
multiple hosts rather than relying on natural infections of different
hosts with different strains. We also controlled the time of bacterial
carriage, thus ensuring that the in vivo adaptation of the bacterial
genome was followed from the onset of establishment in each host.
We identified potential molecular adaptation mechanisms based
on a limited number of point mutations and small deletions that
frequently altered the coding regions (Figure 3, Table S1).
Strikingly, some of these adaptation mechanisms appeared to be
unique for each host, suggesting that the genomic identity of a
bacterial isolate is flexible and relevant in a given host niche.
Sequencing of the re-isolates enabled us to analyze the genome-
wide extent of bacterial adaptation. As the E. coli strain 83972 was
isolated from a young girl, who was colonized for more than three
years [5], it was expected to be well-adapted to growth in urine.
We observed that the number of genomic alterations increased
with prolonged colonization time of the patients, as displayed by
the number of mutations as a function of time (Table 2).
Suboptimal fitness in the new hosts was apparently tailored by
targeting regulators of bacterial metabolism. In consequence, each
of the re-sequenced isolates demonstrated unique adaptations
potentially resulting in growth advantages in their growth
environment (Figure 7). It still remains to be elucidated to what
extend growth conditions in the individual hosts contributed to this
divergent evolution.
Adaptation patterns of the in vivo re-isolates supported the
hypothesis that evolution in individual hosts was driven by positive
selection of genetic variants which are better suited to the
particular host and to some extend probably also by genetic drift.
The results suggest that the genome of prototype ABU isolate E.
coli 83972 is relatively stable as only 34 mutations were detected
after bladder colonization for 423 patient days. To distinguish host
imprinting from stochastic events, we sequenced the polymorphic
positions in re-isolates from repeat inoculation events in each
patient. The reproducibility of some genetic changes indicates that
host-driven genetic change may play an important role in bacterial
microevolution. Certain genetic alterations were detected in re-
isolates from several hosts or from the same host, after
independent inoculations, but not in bacteria propagated in vitro.
Figure 5. Increased fecIR expression due to a T R C transition in the upstream region of fecIR genes in re-isolate PII-4 relative to
parent strain 83972. (A) Growth and luciferase activity of E. coli K-12 carrying pACYC184-based transcriptional reporter gene fusions of sequences
upstream of fecIR from E. coli 83972 or PII-4, respectively, and the promoterless luciferase gene. (B) Electric mobility shift assay (EMSA) showing that
the SNP in the fecIR upstream region of strain PII-4 abolishes tetramer formation of the Fur protein binding to the Fur box. Green, 83972; red, PII-4; D,
Fur protein dimer; T, Fur protein tetramer; O, unbound Cy-3- or Cy-5-labeled DNA oligomer. (C) Model describing binding of the Fur protein to the
upstream region of fecIR. The nucleotide sequence depicted corresponds to the 45-bp Cy-3- or Cy-5-labeled DNA oligomer comprising the Fur
binding site upstream of fecIR used for electrophoretic mobility shift assays. The asterisk indicates the SNP in strain PII-4 relative to parent strain
83972. (D) Alignment of nucleotide sequences of the putative Fur binding site (region in black box) within the fecIR promoter from independent PII
re-isolates. Letters in blue indicate two distinct point mutations acquired during independent colonization episodes.
doi:10.1371/journal.ppat.1001078.g005
In Vivo Adaptation of Uropathogenic E. coli
PLoS Pathogens | www.plospathogens.org 8 August 2010 | Volume 6 | Issue 8 | e1001078
In Vivo Adaptation of Uropathogenic E. coli
PLoS Pathogens | www.plospathogens.org 9 August 2010 | Volume 6 | Issue 8 | e1001078
The number of non-redundant genetic changes observed after
repeated inoculations might on the other hand be explained by
random mutagenesis. We also examined if the adaptive changes
might be cyclic in nature and if, in different patients, the re-isolates
were picked at different cycles. In two of the patients, who carried
E. coli 83972 for more than a hundred days after the initial re-
isolate, we obtained repeat re-isolates and evidence that several
genomic changes were stable in the population.
The impact of host-dependent selection of specific mutants
(‘‘genomic imprinting’’) versus random selection remains to be
defined. Non-synonymous mutations were mainly detected
suggesting that positive selection for structural changes over silent
ones was favored during bladder colonization. Based on the
genomic profile and on mechanisms of susceptibility in human
hosts, several classes of host molecules may be discussed.
Mutations reducing the sensitivity to stress [34,35] or changing
metabolism pointed to specific host processes, as did genes that
became redundant and were lost in the new environment [36,37].
In re-isolates PI-2 and PIII-4, whose gene expression profiles and
genomic alterations indicate adaptation to oxidative stress (Figure 4
and 7), the mutation rate was markedly higher than in the in vitro
propagated strain 4.9 (Table 2), suggesting that in these cases host
response mechanisms, i.e. release of reactive oxygen species may
have triggered bacterial adaptation. In line with this, the analysis
of re-isolate PII-4 did not point towards pronounced adaptation to
oxidative stress and its mutation rate was comparable relative to
the in vitro-propagated E. coli 4.9.
Host resistance to UTI is controlled by innate immunity and
there are genetic differences in innate immune responses between
patients prone to severe, symptomatic infections and those who
Figure 6. Innate immune response to inoculation with E. coli 83972. (A) IL-6 and IL-8 concentrations and neutrophil numbers were quantified
in urine samples obtained from the three patients throughout the colonization period. Kinetics of the host response and time of collection of re-
isolates PI-2, PII-4 and PIII-4. Inset diagrams present the host response parameters to re-inoculations of PII and PIII with E. coli 83972. (B) Median host
responses for cytokines/chemokines in urine. (C) Extended cytokine/chemokine analysis, showing significant differences bwetween the three
patients, except for IL-1a.
doi:10.1371/journal.ppat.1001078.g006
Figure 7. Different adaptational strategies of E. coli 83972 upon prolonged growth in the urinary bladder of human hosts.
Adaptational strategies were deduced from genomic, transcriptomic and proteomic alterations in re-isolates PI-2, PII-4 and PIII-4. Genes in brackets
are mutated in re-isolates relative to their parent E. coli 83972. Adaptation to individual hosts included different metabolic pathways, i.e. utilization of
amino acids, hexuronates or (deoxy-) ribonucleosides; iron uptake and stress protection systems.
doi:10.1371/journal.ppat.1001078.g007
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develop ABU, affecting the IL-8 receptor CXCR1, the IRF3
transcription factor and in TLR4 promoter sequences [38,39,40].
Such differences influence the efficiency of bacterial clearance and
the extent of tissue damage, thus limiting or promoting the
antibacterial host environment [38,41,42,43]. In this study,
differences in innate immune responses to inoculation were
detected, influencing IL-8 secretion and thus the CXCR1-
mediated innate immune response. A second, differentially
regulated pathway reflected events downstream of TRIF and
IRF3, modifying the IL-1/IL-6 signaling pathways. The results
suggest that the patients activate different aspects of the innate
immune response to infection and are consistent with such
responses driving bacterial adaptation. To understand this
complexity is immensely challenging, but our findings illustrate
the need to study microbial interactions within individual hosts in
symptomatic infections versus asymptomatic carriage. It may be
speculated that long-term asymptomatic carriage in a low
responder host combined with attenuation of virulence might be
an excellent mutual strategy.
In ABU patients, bacteria persist as a privileged monoculture,
resembling the normal flora but without the complex microbial
competition characteristic of other mucosal sites. Most ABU E. coli
strains arise from virulent variants by gene loss, suggesting that
attenuation may constitute a survival mechanism for mucosal
pathogens [8,44]. This evolution of commensalism is interesting,
as based on early predictions by Haldane [45], microbial
populations evolve towards virulence. In this proposal, symptoms
caused by the virulent organisms would promote transmission and
the resulting increase in host number would be the most successful
survival mechanism. The present study suggests that ABU bacteria
may evolve towards commensalism rather than virulence, thereby
achieving long-term carriage in individual hosts. While it is
possible that ABU may favor between-host transmission, such
consequences remain to be investigated.
The definition of commensalism has long been debated, and it is
unclear if the relationship identified as commensalism is more
likely to be slightly symbiotic or parasitic. The gut flora (‘‘true
commensals’’) uses nutrients ingested by the host, indicating a
slightly parasitic situation but may outcompete possible pathogens,
indicating symbiosis. It may also be debated whether asymptom-
atic carriage of E. coli in the urinary tract should be considered as
an infection as it represents the establishment of bacteria at a
normally sterile site, or as a condition moving towards symbiosis/
commensalism. The term asymptomatic bacteriuria is generally
used to distinguish colonization from infection and to emphasize
that the presence of bacteria at mucosal surfaces does not always
cause symptoms and tissue damage. We have proposed asymp-
tomatic bacteriuria as a model to study mechanisms underlying
the development of commensalism. In the gut, a complex bacterial
flora makes it technically difficult or impossible to study de novo
responses of microbes to the host environment, unless germ free
mice are used; in itself an artificial situation. As commensalism is
defined as a relationship in which one symbiont, the commensal,
benefits while the other (host) is neither harmed nor helped,
asymptomatic bacteriuria clearly fulfills the definition in many
individuals, while in others the asymptomatic carriage will be
beneficial to both partners, thereby perhaps indicating a more
symbiotic relationship.
Here we present for the first time the complete genome
sequence of an asymptomatic bacteriuria E. coli isolate and the
analysis of bacterial microevolution in the human urinary tract.
We demonstrate that upon prolonged bladder colonization
metabolism, preferentially the exploitation of suitable carbon-
and nitrogen sources in urine, iron uptake and stress resistance of
E. coli 83972 was affected depending on the colonized host. Future
work will analyze the biological relevance of the genomic
alterations observed in this study and show if this knowledge can
help us to identify potential drug targets to decrease bacterial
fitness during symptomatic infections.
Materials and Methods
Ethics statement
The deliberate colonization study has been approved after
written informed consent from the patients by the Medical Ethics
committee, University of Lund, Sweden (Approval no. LU 742-
01/2001).
Patients
Patients with lower urinary tract dysfunctions and recurrent
lower UTI ($3 UTI/year, for two years) were invited to
participate in the study [9]. Their UTI history was confirmed by
the use of interviews and patient records, and patients with a
history of acute pyelonephritis, urological malignancies or
corticosteroid treatment were excluded. Enrolled patients under-
went renal function tests, upper urinary tract imaging and
cystoscopy to exclude renal disease or stone formation. All patients
could not completely empty their bladder upon voiding (residual
urine $100 ml). Bacterial culture records were consulted to
acertain that the UTI episodes were accompanied by significant
bacteriuria ($105 cfu/ml) and that the patient experienced
improvement after antibiotic therapy. Before inoculation, patients
were treated with appropriate antibiotics to sterilize the urine and
after an antibiotic free interval, the patients were catheterized.
After emptying the bladder, 30 ml of E. coli 83972 (105 cfu/ml)
was instilled and the patients were followed according to a defined
study protocol [9]. E. coli 83972 was originally isolated from a girl
with asymptomatic bacteriuria [5] and its ability to cause long
term bacteriuria in patients with dysfunctional voiding is well
documented. The inoculated patients developed long-term,
asymptomatic bacteriuria, experiencing no discomfort, except for
the first 24 hours after catheterization. In a standardized
questionnaire addressing symptoms and need for therapeutic
intervention, no significant events were recorded [6,9].
Throughout the colonization period, monthly urine samples
were collected and analyzed for IL-6 and IL-8 as well as neutrophil
infiltration. For each urine sample urine proteome array analysis
was performed to study the specific host response. Bacteria from
each urine sample were verified by PCR for presence of a kryptic
plasmid unique for strain 83972 and one chromosomal marker
(4.7-kb deletion in strain 83972 in the type 1 fimbrial gene cluster).
For further analysis, five independent colonies per urine sample
were used.
Genome sequencing, assembly and gap closure
Total genomic DNA of E.coli 83972 was mechanically sheared
(HydroShear, GeneMachines) for a Sanger sequencing approach.
A shotgun library based on pCR4.1-TOPO (Invitrogen) was
constructed with the 1.5- to 3-kb size fraction of DNA fragments.
Recombinant plasmids inserts were sequenced using dye termi-
nator chemistry and ABI Prism 3730XL DNA sequencers
(Applied Biosystems). Sequences were processed with Phred and
assembled with the Phrap assembly tool (www.phrap.org).
Additionally, genomic DNA of E.coli 83972 and its re-isolates
was pyrosequenced using a 454 Life Sciences GS-FLX sequencer
(Roche). The 454 reads were assembled using Newbler (Roche).
Sequence editing of shotgun and 454 sequences was done with
GAP4 [46]. For correction of misassembled regions and gap
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closure, PCR or combinatorial multiplex PCR using the Extender
System polymerase (5 Prime) or the TempliPhi Sequence Resolver
kit (GE Healthcare), and primer walking with recombinant
plasmids were applied. For the validation of genetic differences
between the re-isolates and the ancestor strain, single locus
sequencing (Sanger) was performed.
Open reading frames (ORFs) were predicted with YACOP [47].
For annotation, all proteins were screened against Swiss-Prot data
and publicly available protein sequences from other completed
genomes. All predictions were then verified and manually
modified using the ERGO software package (Integrated Geno-
mics) [48]. Complete genome comparisons were done with ACT
[49] based on replicon-specific nucleotide BLAST [50] and with
protein based BiBlast comparisons to selected E.coli genomes
(Wollherr 2009, personal communication). The 83972 genome
sequence reported in this paper has been deposited in the
GenBank database (accession number CP001671).
Strain cultivation
E.coli strain 83972 was routinely grown in vitro in pooled sterile
human urine at 37uC without agitation. For long-term propaga-
tion in vitro, the strain was grown as independent cultures for 68
days (.2000 generations) in pooled sterile human urine at 37uC in
a continous culture.
Pulsed Field Gel Electrophoresis (PFGE)
PFGE was done as previously described (Zdziarski et. al, 2007).
Total RNA isolation
Bacteria were harvested from mid-log phase cultures. Samples
were treated with RNAprotect (Qiagen) and extracted using the
RNeasy mini kit (Qiagen). DNA traces were removed by RNase-
free DNase I (New England Biolabs).
Array hybridization and data processing
For expression profiling, custom-tailored oligonucleotide micro-
arrays (Operon Biotechnologies) were used. The custom array
contained 10,816 longmer oligonucleotide probes covering the
complete genomes of six E.coli strains (non-pathogenic E.coli K-12
strain MG1655, EHEC O157:H7 strains EDL933 and Sakai,
UPEC strains CFT073, 536 and UTI89, pOSAK1, pO157_Sakai,
pO157_EDL933 and pUTI89).
10 mg of total RNA were reverse transcribed (SuperScript III,
Invitrogen) with direct incorporation of fluorescently labelled
(Cy3- or Cy5-) dCTP (GE Healthcare). 160 pmol of each Cy-3
and Cy-5 labelled probe were used for hybridisation. For each
experiment, at least three independent hybridizations were
performed. Hybridized and washed slides were scanned using a
GenePix 4000B Microarray Scanner (GE Healthcare) with a
resolution of 10 mm pixel size.
Outer membrane protein isolation
Outer membrane protein (OMP) preparations from bacteria
were performed as described previously [27].
Two-dimensional protein gel electrophoresis
Proteome analysis was performed with 300 mg OMP samples as
described previously [27]. Coomassie G-250-stained gels were scanned
and analyzed with the Delta-2D Software (http://www.decodon.com).
Mass spectrometry
Protein spots were excised from stained 2-D gels. Following
tryptic digestion, MALDI-TOF measurement was carried out with
the 4800 MALDI TOF/TOF Analyzer (Applied Biosystems). The
Mascot search engine version 2.1 (Matrix Science Ltd, London,
UK) was used for data base search with a specific E. coli sequence
database.
Luciferase measurements
The 485-bp upstream region of fecIR was fused with the
promoterless luciferase gene cluster luxABCDE in pACYC184.
Plasmids with the transcriptional reporter gene fusions were
transformed into E. coli strain DH5a and grown at 37uC in Luria
broth. 100 ml samples were withdrawn after 3 hours of growth and
light emission was recorded with a luminometer (Berthold). To test
the luciferase activity directly on LB agar plates, bacterial
luminescence was recorded with the ChemiLux photoimager
(Intas).
E. coli Fur expression and purification
E. coli Fur protein was purified with the IMPACT protein
purification system (New England Biolabs) according to the
manufacturer’s instructions. The fur sequence was amplified using
primers Fur_up_NdeI (59-GGTGGTCATATGACTGATAA-
CAATACCGCCC-39) and Fur_down_SapI (59-GGTGGTTG-
CTCTTCCGCATTTGCCTTCGTGCGCGTGCTC-39).
Electrophoretic Mobility Shift Assay (EMSA)
A 45-bp Cy3- or Cy5-labeled DNA oligomer (Operon)
comprising the Fur binding site upstream of fecIR (tccaattgtaatga-
taaccattctcatattaatatgactacgtga-Cy3 – 83972; tccaattgtaatgataac-
cattctcatgttaatatgactacgtga-Cy5 – PII-4) was annealed with an
unlabeled complementary 45-bp oligomer in annealing buffer
(10 mM Tris-HCl, 50 mM NaCl, 1 mM EDTA; 95uC–5 min,
67uC–20 min, 30uC–1 h). EMSAs were performed as previously
described [52]. Gels were subsequently scanned on a Typhoon
variable mode imager (Molecular Dynamics).
Innate immune response parameters in urine
Neutrophil numbers were counted in un-centrifuged fresh urine
using a Bu¨rker chamber [53]. IL-6 and IL-8 concentrations in
fresh urine samples were determined in the Lund University
hospital routine lab using an Immulite 1000 (Siemens). The
detection limits were 2.8 pg/ml (IL-6) and 5 ng/ml (IL-8).
Samples with undetectable cytokine concentrations were assigned
the value of lower detection limit. For extended cytokine/
chemokine profiling, we used the MILLIPLEX MAP Human
Cytokine/Chemokine Panel to detect IL-1RA, MCP-1, IL-1a,
GRO-a, IP-10 and sIL-2Ra. The analysis was according to the
manufacturer’s protocol and measurements were in duplicates on
a Luminex 200 instrument (Luminex Corp.).
Statistics
The Freidman test with Dunn’s post test was used for
comparisons of innate host responses.
Supporting Information
Figure S1 Genomic fingerprints of E. coli 83972 re-isolates.
Pulsed field gel electrophoresis patterns of consecutive in vivo (A) as
well as of in vitro-propagated isolates (B) of E. coli 83972 are shown.
Arabic numbers indicate the order of sampling time points of
consecutive in vivo re-isolates. in vitro: 17 independent colonies were
picked after more than 2000 generations of continuous culture in
pooled human urine. The genome structure was assessed by PFGE
following XbaI (left panel) and AvrII (right panel) digestion.
Found at: doi:10.1371/journal.ppat.1001078.s001 (1.11 MB PDF)
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Figure S2 Genotypic characterization of E. coli 83972 re-
isolates. (A) Genome structure analysis of different clones from
the same urine sample, by PFGE following AvrII digestion. With
one exception (PIII-4_2), all clones exhibited the same restriction
pattern, therefore re-isolates PI-2, PII-4 and PIII-4 are the major
fraction of analyzed urine samples. The restriction patterns of
parent strain 83972 and re-isolate PIII-4_2 were identical. (B)
Genome sizes of E. coli 83972 re-isolates, analyzed by PFGE
following I-CeuI digestion. Only one re-isolate, PII-4, had a
reduced genome size relative to parent strain 83972. (C) Genome
size reduction in re-isolate PII-4 due to loss of the iucABCD, iutA
and sat genes by partial deletion (27 kb) of a pathogenicity island
during in vivo growth.
Found at: doi:10.1371/journal.ppat.1001078.s002 (0.14 MB PDF)
Figure S3 Phenotypic traits of E. coli 83972 re-isolates. (A)
Identical growth rates of E. coli 83972 and its in vivo and in vitro re-
isolates in pooled human urine (mean values of . three
experiment). (B) Isolate PIII-4 shows increased motility in soft
agar with pooled human urine. (C) Reduced biofilm formation in
pooled human urine of strains PI-2 and PIII-4 relative to 83972.
Mean values of . three experiments. Bonferroni’s Multiple
Comparison Test was used for statistical analysis.
Found at: doi:10.1371/journal.ppat.1001078.s003 (0.08 MB PDF)
Figure S4 Outer membrane proteome comparison of E. coli
83972 (green) and re-isolate PIII-4 (red) upon in vitro growth in
pooled human urine. Proteins with similar expression level are
indicated in yellow.
Found at: doi:10.1371/journal.ppat.1001078.s004 (1.39 MB PDF)
Figure S5 Different nutritional strategies of in vivo re-isolate PIII-
4. (A) Altered expression of sugar transport and degradation
pathways in the re-isolate PIII-4. (B) Adaptation of D-serine
catabolism and nitrogen assimilation to growth in urine in re-
isolate PIII-4. Red and black arrows indicate up-regulated and
down-regulated genes, respectively, of re-isolate relative to parent
strain 83972 during in vitro growth in pooled human urine.
Found at: doi:10.1371/journal.ppat.1001078.s005 (1.39 MB PDF)
Figure S6 Outer membrane proteome comparison of E. coli
83972 (green) and re-isolate PI-2 (red) upon in vitro growth in
pooled human urine. Proteins with similar expression level are
indicated in yellow.
Found at: doi:10.1371/journal.ppat.1001078.s006 (1.72 MB PDF)
Figure S7 Outer membrane proteome comparison of E. coli
83972 (green) and re-isolate PII-4 (red) upon in vitro growth in
pooled human urine. Proteins with similar expression level are
indicated in yellow.
Found at: doi:10.1371/journal.ppat.1001078.s007 (0.73 MB PDF)
Figure S8 Different nutritional strategies of in vivo re-isolate PII-
4. (A) Adaptation of the ribonucleoside degradation pathway in re-
isolate PII-4. (B) Adaptation of the deoxy-ribonucleoside degra-
dation pathway in re-isolate PII-4. Red arrows indicate up-
regulated genes of re-isolate relative to parent strain 83972 during
in vitro growth in pooled human urine.
Found at: doi:10.1371/journal.ppat.1001078.s008 (0.07 MB PDF)
Figure S9 Eight-fold increase in luciferase activity upon fusion
of fecIR upstream region of re-isolate PII-4 with the promoterless
luciferase genes relative to the fecIR upstream region of parent
strain 83972. Paired t test was performed for statistical analysis.
Found at: doi:10.1371/journal.ppat.1001078.s009 (0.05 MB PDF)
Table S1 Genomic alterations in in vivo and in vitro re-isolates
relative to parent strain 83972.
Found at: doi:10.1371/journal.ppat.1001078.s010 (0.02 MB PDF)
Table S2 Summary of SNPs detected in candidate genes of re-
isolates from two independent bladder colonization.
Found at: doi:10.1371/journal.ppat.1001078.s011 (0.01 MB PDF)
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